-
1Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
المؤلفون: Benjamin O. Lawson, Hung Thieu Khong, Junjie Ma, Joan Van Atta, Cheryl McGovern, Brian Khong, Abhijit Ray
المصدر: BMC Cancer, Vol 18, Iss 1, Pp 1-5 (2018)
BMC Cancerمصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Metastatic melanoma, Fever, Meperidine, Antineoplastic Agents, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, 030202 anesthesiology, Surgical oncology, Renal cell carcinoma, High dose interleukin-2, Internal medicine, Genetics, medicine, Humans, Renal Insufficiency, Adverse effect, Carcinoma, Renal Cell, Melanoma, Tramadol, Neoplasm Staging, Retrospective Studies, Dose-Response Relationship, Drug, Rigor prophylaxis, business.industry, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Kidney Neoplasms, Treatment Outcome, Oncology, Opioid, 030220 oncology & carcinogenesis, Stage iv melanoma, Interleukin-2, Female, Immunotherapy, business, medicine.drug, Research Article
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa5d8ec79bc3e62627e21743f468623aTest
http://link.springer.com/article/10.1186/s12885-018-4810-yTest -
2
المؤلفون: Bret Taback, William H. Sharfman, Merve Hasanov, Gary C. Doolittle, Lee D. Cranmer, Lawrence E. Flaherty, Sigrun Hallmeyer, Nancy C. Gregory, Ralph J. Hauke, Gregory A. Daniels, Lynn G. Feun, Sapna Pradyuman Patel, Denái R. Milton, Mohammed M. Milhem
المصدر: OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology
article-version (VoR) Version of Recordمصطلحات موضوعية: Interleukin 2, medicine.medical_specialty, Metastatic melanoma, Immunology, Population, Ipilimumab, Gastroenterology, Aldesleukin, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Immunology and Allergy, ipilimumab, Adverse effect, education, Melanoma, RC254-282, education.field_of_study, high dose interleukin-2, Intention-to-treat analysis, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, clinical trial, RC581-607, Recombinant Proteins, Clinical trial, Nivolumab, Oncology, Interleukin-2, Immunologic diseases. Allergy, business, Research Article, medicine.drug, metastatic melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce7212a003c5762b30ac542bc70ee08bTest
https://doaj.org/article/8301b9196dbd4b3ab906e344ff9c4301Test -
3
المؤلفون: Alicia Ali, Olesia Kellezi, Ajjai Alva, Joseph J. Park, Reema Hamasha
المصدر: Cancer Treatment and Research Communications, Vol 25, Iss, Pp 100251-(2020)
مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Ipilimumab, Immune checkpoint inhibitor, Pembrolizumab, 03 medical and health sciences, 0302 clinical medicine, High dose interleukin-2, Internal medicine, Medicine, Humans, Adverse effect, Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, RC254-282, Retrospective Studies, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Middle Aged, medicine.disease, Discontinuation, Clear cell renal cell carcinoma, Nivolumab, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed8f85fc3c94395541250a2ad492b0feTest
https://pubmed.ncbi.nlm.nih.gov/33310369Test -
4
المؤلفون: Theodore F. Logan, Lee D. Cranmer, Jatinder Singh, Sanjiv S. Agarwala, Bret Taback, Theresa L. Luna, Christopher D. Lao, Marc S. Ernstoff, Sandra Aung, Lawrence E. Flaherty, Jose Lutzky, Brendan D. Curti, David H. Lawson, Joseph I. Clark
المصدر: Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-8 (2018)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer--Immunotherapy, Cancer Research, medicine.medical_treatment, Phases of clinical research, 0302 clinical medicine, Cancer immunotherapy, Immunology and Allergy, Neoplasm Metastasis, Multicenter, Vemurafenib, Melanoma, Melanoma--Treatment, Enzyme inhibitors, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Phase II, Treatment Outcome, 030220 oncology & carcinogenesis, Cohort, Disease Progression, Molecular Medicine, Female, Research Article, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, Interleukin 2, medicine.medical_specialty, Immunology, Antineoplastic Agents, lcsh:RC254-282, Drug Administration Schedule, Young Adult, 03 medical and health sciences, Therapeutic approach, BRAF-mutated metastatic melanoma, Internal medicine, medicine, Humans, Aged, Neoplasm Staging, Pharmacology, business.industry, Immunotherapy, medicine.disease, Survival Analysis, High-dose interleukin-2, 030104 developmental biology, Mutation, Interleukin-2, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d3a27f96c4ad52f5576625b9be7702dTest
https://doi.org/10.1186/s40425-018-0387-xTest -
5
المؤلفون: Karl D. Lewis, Thomas Olencki, Thomas W. Flaig, Anthony Jarkowski, Dexiang Gao, Bruce G. Redman, Theodore F. Logan, Marcus Bolden, Elaine T. Lam, Neeraj Agarwal, Timothy M. Kuzel, Arun Sendilnathan, Paul Monk, Jamie Poust, Michael K.K. Wong
المصدر: Journal of Immunotherapy (Hagerstown, Md. : 1997)
مصطلحات موضوعية: Adult, Male, Sorafenib, renal cell carcinoma, Cancer Research, medicine.medical_specialty, tyrosine kinase inhibitor (TKI), sunitinib, Immunology, Antineoplastic Agents, Risk Factors, Renal cell carcinoma, Internal medicine, Clinical Studies, medicine, Carcinoma, Humans, Immunology and Allergy, high-dose interleukin-2, Neoplasm Metastasis, Adverse effect, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Retrospective Studies, Pharmacology, medicine.diagnostic_test, business.industry, Sunitinib, Cardiac stress test, Retrospective cohort study, Middle Aged, Prognosis, medicine.disease, Kidney Neoplasms, 3. Good health, Surgery, Treatment Outcome, Cardiovascular Diseases, Heart failure, Interleukin-2, Female, sorafenib, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef0a500825e445ce76e21c087d2895c9Test
https://doi.org/10.1097/cji.0000000000000044Test -
6
المؤلفون: Neeraj Agarwal, Joseph Merriman, David D. Stenehjem, David Gill, Anitha Alex, Shiven B. Patel, Archana M. Agarwal, Andrew W. Hahn, Dan Albertson, James Arthur Kuzman
المصدر: BMC Urology
مصطلحات موضوعية: Male, 0301 basic medicine, Interleukin 2, Oncology, medicine.medical_specialty, Neutrophils, Urology, Lymphocyte, medicine.medical_treatment, Antineoplastic Agents, Cohort Studies, Leukocyte Count, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, High dose interleukin-2, Renal cell carcinoma, Internal medicine, medicine, Humans, Lymphocytes, Progression-free survival, Carcinoma, Renal Cell, Retrospective Studies, business.industry, fungi, General Medicine, Immunotherapy, Middle Aged, medicine.disease, Kidney Neoplasms, 3. Good health, Treatment Outcome, Neutrophil lymphocyte ratio, 030104 developmental biology, medicine.anatomical_structure, Reproductive Medicine, 030220 oncology & carcinogenesis, Cohort, Immunology, Absolute neutrophil count, Interleukin-2, Biomarker (medicine), Female, business, Biomarkers, Research Article, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d12e3ea37a7f55189c04eea1563d84bTest
https://doi.org/10.1186/s12894-016-0192-0Test -
7
المؤلفون: Varun Sreenivasan, Arkadiusz Z. Dudek
المصدر: Case Reports in Oncology
Case Reports in Oncology, Vol 6, Iss 1, Pp 78-83 (2013)مصطلحات موضوعية: Oncology, Interleukin 2, medicine.medical_specialty, Levetiracetam, medicine.medical_treatment, lcsh:RC254-282, Published online: January, 2013, Internal medicine, otorhinolaryngologic diseases, Medicine, Melanoma, Dystonia, business.industry, Brain metastasis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, High-dose interleukin-2, Surgery, nervous system diseases, Radiation therapy, business, Complication, Gamma Knife therapy, medicine.drug, Potential toxicity
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14f0f7906c598acd83fcb903c2d8be2Test
http://europepmc.org/articles/PMC3573788Test -
8
المؤلفون: Neeraj Agarwal, Andrew W. Hahn, Archana M. Agarwal, Wolfram E. Samlowski, Srinivas K. Tantravahi, David Gill, Joseph Merriman, Kinjal Parikh, Arun Sendilnathan, Sumati Gupta, David D. Stenehjem
المصدر: ecancermedicalscience
مصطلحات موضوعية: Interleukin 2, Cancer Research, medicine.medical_specialty, medicine.drug_class, 030232 urology & nephrology, Context (language use), Gastroenterology, Tyrosine-kinase inhibitor, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Conditional survival, Renal cell carcinoma, Internal medicine, medicine, high-dose interleukin-2, Gynecology, metastatic renal cell cancer, conditional survival, Performance status, business.industry, medicine.disease, Vascular endothelial growth factor, Oncology, chemistry, Clinical Study, business, Clear cell, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aadf28dc0a0c44cae7ee5deb3dac9156Test
https://pubmed.ncbi.nlm.nih.gov/27729941Test -
9
المؤلفون: Lauren C. Harshman, Benjamin I. Chung, Parth K. Modi, Francisco Gelpi-Hammerschmidt, Toni K. Choueiri, Christopher B. Allard, Eric A. Singer, Ilker Tinay, Izak Faiena, Steven L. Chang
المساهمون: Allard, Christopher B., Gelpi-Hammerschmidt, Francisco, Harshman, Lauren C., Choueiri, Toni K., Faiena, Izak, Modi, Parth, Chung, Benjamin I., Tinay, Ilker, Singer, Eric A., Chang, Steven L.
المصدر: Urologic oncology. 33(11)
مصطلحات موضوعية: Male, medicine.medical_treatment, MELANOMA, Disease, law.invention, Cohort Studies, DOUBLE-BLIND, Therapy trends, Renal cell carcinoma, law, Neoplasm Metastasis, Kidney cancer, Middle Aged, Prognosis, CANCER, Intensive care unit, STATISTICS, Kidney Neoplasms, Oncology, Tolerability, SAFETY, Cohort, SURVIVAL, Female, Immunotherapy, Hemodialysis, medicine.medical_specialty, Urology, Antineoplastic Agents, Article, Internal medicine, medicine, Humans, Carcinoma, Renal Cell, Aged, Neoplasm Staging, Toxicity, Dose-Response Relationship, Drug, business.industry, medicine.disease, High-dose interleukin-2, United States, ANTIBODY, Immunology, Interleukin-2, INTERFERON-ALPHA, business, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de577ed8edd7650b7f40d0325caf8646Test
https://pubmed.ncbi.nlm.nih.gov/26210683Test